PC707 Finals Frequently Tested Exam
Questions With Verified Multiple Choice
and Conceptual Actual 100% Correct
Detailed Answers
Guaranteed Pass!!Current Update!!
1. Which of the following are rapid–acting insulins?
A. Regular insulin
B. Aspart (Novolog)
C. Glargine (Lantus)
D. Detemir (Levemir)
Answer: B
2. Which insulin is the rapid-acting inhaled formulation?
A. Lispro
B. Afrezza
C. NPH
D. Detemir
Answer: B
3. Rapid-acting insulins are primarily indicated for:
A. Basal glycemic control only
B. Administering with meals to control postprandial glucose
,C. Treatment of ketoacidosis only
D. Night-only dosing
Answer: B
4. In Type 1 diabetes, rapid-acting insulin must be used with:
A. Glucagon
B. Oral agents
C. Intermediate or long-acting insulin
D. No additional medications
Answer: C
5. What is the mechanism of action (MOA) of insulin?
A. Stimulates alpha cells to release glucagon
B. Mimics endogenous insulin and promotes GLUT4 insertion
C. Increases hepatic glucose production
D. Inhibits pancreatic beta cells
Answer: B
6. What is the MOA of Afrezza?
A. Long-acting basal insulin
B. Ultra-long acting depot formulation
C. Rapid mealtime insulin with faster onset and shorter duration
D. Increases insulin receptor sensitivity
Answer: C
7. Which of the following is specific to Afrezza as a side effect?
A. Peripheral edema
B. Acute bronchospasm in patients with chronic lung disease
, C. Lipodystrophy
D. Hypokalemia
Answer: B
8. Insulin should be used with caution in patients with:
A. Hypertension
B. Hypoglycemia
C. Asthma
D. Kidney stones
Answer: B
9. What is the onset of action for Lispro (Humalog)?
A. 1–2 hours
B. 15–30 minutes
C. Immediate
D. 45 minutes
Answer: B
10. What is the peak effect of Lispro (Humalog)?
A. 6–8 hours
B. 2–4 hours
C. 0.5–2.5 hours
D. No peak
Answer: C
11. What is the duration of Lispro?
A. 10 hours
B. 3–6 hours
Questions With Verified Multiple Choice
and Conceptual Actual 100% Correct
Detailed Answers
Guaranteed Pass!!Current Update!!
1. Which of the following are rapid–acting insulins?
A. Regular insulin
B. Aspart (Novolog)
C. Glargine (Lantus)
D. Detemir (Levemir)
Answer: B
2. Which insulin is the rapid-acting inhaled formulation?
A. Lispro
B. Afrezza
C. NPH
D. Detemir
Answer: B
3. Rapid-acting insulins are primarily indicated for:
A. Basal glycemic control only
B. Administering with meals to control postprandial glucose
,C. Treatment of ketoacidosis only
D. Night-only dosing
Answer: B
4. In Type 1 diabetes, rapid-acting insulin must be used with:
A. Glucagon
B. Oral agents
C. Intermediate or long-acting insulin
D. No additional medications
Answer: C
5. What is the mechanism of action (MOA) of insulin?
A. Stimulates alpha cells to release glucagon
B. Mimics endogenous insulin and promotes GLUT4 insertion
C. Increases hepatic glucose production
D. Inhibits pancreatic beta cells
Answer: B
6. What is the MOA of Afrezza?
A. Long-acting basal insulin
B. Ultra-long acting depot formulation
C. Rapid mealtime insulin with faster onset and shorter duration
D. Increases insulin receptor sensitivity
Answer: C
7. Which of the following is specific to Afrezza as a side effect?
A. Peripheral edema
B. Acute bronchospasm in patients with chronic lung disease
, C. Lipodystrophy
D. Hypokalemia
Answer: B
8. Insulin should be used with caution in patients with:
A. Hypertension
B. Hypoglycemia
C. Asthma
D. Kidney stones
Answer: B
9. What is the onset of action for Lispro (Humalog)?
A. 1–2 hours
B. 15–30 minutes
C. Immediate
D. 45 minutes
Answer: B
10. What is the peak effect of Lispro (Humalog)?
A. 6–8 hours
B. 2–4 hours
C. 0.5–2.5 hours
D. No peak
Answer: C
11. What is the duration of Lispro?
A. 10 hours
B. 3–6 hours
